Legal Representation
Attorney
NADINE P. FLYNN
USPTO Deadlines
Application History
27 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Dec 22, 2005 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
Dec 22, 2005 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
Apr 1, 2005 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
Mar 9, 2005 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Mar 9, 2005 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
Sep 30, 2004 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
Sep 17, 2004 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Sep 17, 2004 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
Apr 6, 2004 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
Apr 1, 2004 | CFIT | O | CASE FILE IN TICRS | Loading... |
Mar 15, 2004 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Mar 15, 2004 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
Sep 26, 2003 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Sep 17, 2003 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Sep 17, 2003 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Apr 22, 2003 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Feb 25, 2003 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Feb 25, 2003 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Oct 15, 2002 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Jul 23, 2002 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Jul 3, 2002 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
Apr 30, 2002 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Apr 4, 2002 | I | PAPER RECEIVED | Loading... | |
Apr 4, 2002 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Apr 2, 2002 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Nov 9, 2001 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
Oct 22, 2001 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
PRAVA PROTECT PACK
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PACK"